Given the central role of PNPLA3 in the progression and development of MASLD, numerous studies have been conducted to elucidate the function of this protein, particularly the effects caused by the p.I148M minor allele. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.